These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33441515)

  • 21. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report.
    Nasiri A; Lami A; Alhumaidi A; Madkhali A; Althaqib A; Aljarwan N; Alkharras R
    Cureus; 2023 Apr; 15(4):e37016. PubMed ID: 37026111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
    Pollyea DA; Altman JK; Assi R; Bixby D; Fathi AT; Foran JM; Gojo I; Hall AC; Jonas BA; Kishtagari A; Lancet J; Maness L; Mangan J; Mannis G; Marcucci G; Mims A; Moriarty K; Mustafa Ali M; Neff J; Nejati R; Olin R; Percival ME; Perl A; Przespolewski A; Rao D; Ravandi F; Shallis R; Shami PJ; Stein E; Stone RM; Sweet K; Thota S; Uy G; Vachhani P; Cassara CJ; Freedman-Cass DA; Stehman K
    J Natl Compr Canc Netw; 2023 May; 21(5):503-513. PubMed ID: 37156478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of diagnostic efficacy of NRP-1/CD304 in hematological diseases.
    Liu YJ; Li XH; Song YL; Zhou YC; Cai RZ; Chi PD
    Cancer Med; 2023 May; 12(10):11284-11292. PubMed ID: 36965095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Blastic plasmacytoid dendritic cell neoplasm accompanied by chronic myelomonocytic leukemia successfully treated with azacitidine].
    Sukegawa S; Sakata-Yanagimoto M; Matsuoka R; Momose H; Kiyoki Y; Noguchi M; Nakamura N; Watanabe R; Fujimoto M; Yokoyama Y; Nishikii H; Kato T; Kusakabe M; Kurita N; Obara N; Hasegawa Y; Chiba S
    Rinsho Ketsueki; 2018; 59(12):2567-2573. PubMed ID: 30626790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
    Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
    Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracytoplasmic detection of TCL1--but not ILT7-by flow cytometry is useful for blastic plasmacytoid dendritic cell leukemia diagnosis.
    Angelot-Delettre F; Biichle S; Ferrand C; Seilles E; Gaugler B; Harrivel V; Rosenthal-Allieri MA; Deconinck E; Saas P; Garnache-Ottou F
    Cytometry A; 2012 Aug; 81(8):718-24. PubMed ID: 22674796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of blastic plasmacytoid dendritic cell neoplasm.
    Sullivan JM; Rizzieri DA
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):16-23. PubMed ID: 27913457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blastic Plasmacytoid Dendritic Cell Neoplasm in Long-Term Complete Remission After Venetoclax Monotherapy.
    Sasaki Y; Murai S; Shiozawa E; Yamochi T; Hattori N
    Cureus; 2024 Jan; 16(1):e52446. PubMed ID: 38371152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
    Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
    Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax.
    Montero J; Stephansky J; Cai T; Griffin GK; Cabal-Hierro L; Togami K; Hogdal LJ; Galinsky I; Morgan EA; Aster JC; Davids MS; LeBoeuf NR; Stone RM; Konopleva M; Pemmaraju N; Letai A; Lane AA
    Cancer Discov; 2017 Feb; 7(2):156-164. PubMed ID: 27986708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W; Zhang L; Horna P; Sokol L
    Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
    Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
    Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
    [No Abstract]   [Full Text] [Related]  

  • 34. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
    Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
    J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastic Plasmacytoid Dendritic Cell Neoplasm: How do You Distinguish It from Acute Myeloid Leukemia?
    Reichard KK
    Surg Pathol Clin; 2013 Dec; 6(4):743-65. PubMed ID: 26839196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic analysis of myeloperoxidase-negative leukemia cutis and blastic plasmacytoid dendritic cell neoplasm.
    Cronin DM; George TI; Reichard KK; Sundram UN
    Am J Clin Pathol; 2012 Mar; 137(3):367-76. PubMed ID: 22338048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
    Tsagarakis NJ; Kentrou NA; Papadimitriou KA; Pagoni M; Kokkini G; Papadaki H; Pappa V; Marinakis T; Anagnostopoulos NI; Vadikolia C; Anagnostopoulos A; Angelopoulou MK; Terpos E; Poziopoulos C; Anargyrou K; Rontogianni D; Papadaki T; Psarra A; Kontopidou FN; Skoumi D; Papadhimitriou SI; Paterakis G;
    Leuk Res; 2010 Apr; 34(4):438-46. PubMed ID: 19793612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case.
    Al-Alwan A; Khalid F; Vyas C; Sirpal V; Bader H
    J Community Hosp Intern Med Perspect; 2023; 13(4):79-81. PubMed ID: 37868236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
    Roussel X; Garnache Ottou F; Renosi F
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.